Roth Capital Partners raises target price for Bionomics (ASX: BNO) from USD$1.50 to USD$2.60: Full Report
Bionomics Limited (ASX: BNO, OTCQX:BNOEF) to present anti-anxiety drug treatment trial results and ADHD treatment research at ECNP
You must be logged in to post a comment.